Financing ·
Vivos Inc designates 1M shares of Series D Convertible Preferred Stock with $1 stated value
RDGLVivos Inc
On September 28, 2026, Vivos Inc filed a Certificate of Designations creating 1.0 million shares of Series D Convertible Preferred Stock. Each share carries a $1.00 stated value and liquidation preference, ranking senior to common stock. The preferred stock is convertible into common shares at a rate derived from the $1.00 stated value divided by $0.08. Holders receive voting rights equivalent to fifty votes per common share issuable upon conversion. A beneficial ownership limitation restricts conversion if it would result in owning more than 4.99% of outstanding common stock, unless increased to 9.99% with notice. Vivos Inc operates in the biotechnology sector, focusing on cancer treatment technologies.